Dr Lim studied medicine at the National University of Singapore and he was on the Dean’s List every year, graduating as the top of his cohort. He was awarded the prestigious Lee Kuan Yew Gold Medal, recognising the best graduate throughout the course of study. He trained at the Singapore National Eye Centre, and was the top-ranked candidate in vitreo-retinal diseases, paediatric ophthalmology, and oculoplastic and adnexal diseases, for the final Academy of Medicine of Singapore Ophthalmology exit examinations.
He subsequently qualified as a Fellow for both the Royal College of Surgeons of Edinburgh and the Academy of Medicine of Singapore. He then pursued advanced training at Harvard Medical School and worked with leaders in the field at the Massachusetts Eye and Ear Infirmary. He received further sub-specialty training in paediatric retinal conditions, and valuable exposure to ‘bionic eye’ procedures and technology. He is one of the first in the region to have knowledge and experience in this exciting new field.
Prior to joining National University Hospital, Dr Lim served as a Senior Consultant in the Surgical Retina Department at the Singapore National Eye Centre as well as a Visiting Senior Consultant Retina Surgeon at Changi General Hospital. He was also a Visiting Senior Consultant at FV Hospital in Ho Chi Minh City, Vietnam.
Dr Lim specialises in medical and surgical management of both adult and paediatric retinal diseases which include:
• Age-related macular degeneration
• Diabetic retinopathy
• Floaters & retinal detachment in adults
• Macular surgery (macular holes, epiretinal membranes)
• Retinopathy of prematurity in children
He also practises general ophthalmology and offers cataract surgery and other procedures using the latest surgical techniques.
As a firm believer of translational research which leverages on the development, dissemination and integration of research into clinical practice, he is a keen and active researcher. He has authored more than 50 publications and published in top-tier journals such as The Lancet, New England Journal of Medicine and the Journal of American Medical Association and received grants awarded by the National Medical Research Council.
1. Lim LS, Ng WY, Wong D, Wong E, Yeo I, Ang CL, Kim L, Vavvas D, Lee SY. Prognostic factor analysis of vitrectomy for myopic foveoschisis. Br J Ophthalmol. 2015 Dec;99(12):1639-43.
2. Lim LS, Chua S, Tan PT, Cai S, Chong YS, Kwek K, Gluckman PD, Fortier MV, Ngo C, Qiu A, Saw SM. Eye size and shape in newborn children and their relation to axial length and refraction at 3 years. Ophthalmic Physiol Opt. 2015 Jul;35(4):414-23.
3. Lim LS, Ang CL, Wong E, Wong DW, Tan DT. Vitreoretinal complications and vitreoretinal surgery in osteo-odonto-keratoprosthesis surgery. Am J Ophthalmol. 2014 Feb;157(2):349-54. doi: 10.1016/j.ajo.2013.08.033. Epub 2013 Oct 16.
4. Lim LS, Tsai A, Wong D, Wong E, Yeo I, Loh BK, Ang CL, Ong SG, Lee SY. Prognostic factor analysis of vitrectomy for retinal detachment associated with myopic macular holes. Ophthalmology. 2014 Jan;121(1):305-310.
5. Lim LS, Chong GH, Tan PT, Chong YS, Kwek K, Gluckman PD, Fortier MV, Saw SM, Qiu A. Distribution and determinants of eye size and shape in newborn children: a magnetic resonance imaging analysis. Invest Ophthalmol Vis Sci. 2013 Jul 16;54(7):4791-7.
6. Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012 May 5;379(9827):1728-38.
7. Lim LS, Wong TY. Fibrate use in the United States and Canada. JAMA. 2011 Jul 13;306(2):157-8;
8. Lim LS, Mitchell P, Wong TY. Bevacizumab for retinopathy of prematurity. N Engl J Med. 2011 Jun 16;364(24):2360.
9. Lim LS, Liew G, Cheung N, Mitchell P, Wong TY. Mixed messages on systemic therapies for diabetic retinopathy. Lancet. 2010 Oct 30;376(9751):1461.
10. Lim LS, Gazzard G, Low YL, Choo R, Tan DT, Tong L, Yin Wong T, Saw SM. Dietary factors, myopia, and axial dimensions in children. Ophthalmology. 2010 May;117(5):993-997.